Breaking News Instant updates and real-time market news.

2020-11-30 09:03:59 CMTL Comtech $20.40 / +0.23 (+1.14%) 09:03 11/30/20 11/30 09:03 11/30/20 09:03	Comtech awarded $2.4M contract from City of Edmonton Comtech Telecommunications announced, that during its first quarter of fiscal 2021, Comtech Solacom Technologies, Inc., a division of Comtech's Commercial Solutions segment, was awarded a Next Generation 911 services contract from the City of Edmonton. The $2.4 million contract value includes option years and was initially funded at $1.6 million, which Comtech booked in its first quarter of fiscal 2021. The City of Edmonton is one of the latest customers to join Comtech Solacom's growing global customer base in Australia, Canada, New Zealand and the United States.	08 Dec
CMTL Comtech $20.40 / +0.23 (+1.14%) 09/22/20 Fly Intel: Top five analyst downgrades 06/04/20 Northland Comtech price target lowered to $24 from $27 at Northland 03/31/20 Citi Comtech price target lowered to $17 from $34 at Citi

2020-11-30 09:03:59

CMTL

Comtech

$20.40 / +0.23 (+1.14%)

09:03

11/30/20

11/30

09:03

11/30/20

09:03

Comtech awarded $2.4M contract from City of Edmonton

Comtech Telecommunications announced, that during its first quarter of fiscal 2021, Comtech Solacom Technologies, Inc., a division of Comtech's Commercial Solutions segment, was awarded a Next Generation 911 services contract from the City of Edmonton. The $2.4 million contract value includes option years and was initially funded at $1.6 million, which Comtech booked in its first quarter of fiscal 2021. The City of Edmonton is one of the latest customers to join Comtech Solacom's growing global customer base in Australia, Canada, New Zealand and the United States.

08
Dec

CMTL Comtech

$20.40 / +0.23 (+1.14%)

09/22/20: Fly Intel: Top five analyst downgrades

06/04/20 Northland: Comtech price target lowered to $24 from $27 at Northland

03/31/20 Citi: Comtech price target lowered to $17 from $34 at Citi

TODAY'S FREE FLY STORIES

Hot Stocks	CytomX Therapeutics announces $75M offering of common stock » 16:36 01/19/21 01/19 16:36 01/19/21 16:36 CTMX CytomX Therapeutics $8.48 / +0.55 (+6.94%) CytomX expects to use the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CTMX CytomX Therapeutics $8.48 / +0.55 (+6.94%) 08:32 Today CytomX Therapeutics announces employment inducement grants 11/05/20 CytomX Therapeutics treats first patient in Phase 2 expansion study of CX-2029 10/06/20 CytomX Therapeutics announces retirement of CSO Michael Kavanaugh 09/18/20 CytomX Therapeutics announces employment inducement grants CTMX CytomX Therapeutics $8.48 / +0.55 (+6.94%) 09/22/20 Guggenheim Guggenheim taking more conservative view, downgrades CytomX to Neutral 09/22/20 Guggenheim CytomX Therapeutics downgraded to Neutral from Buy at Guggenheim 09/15/20 Citi CytomX Therapeutics price target lowered to $8.50 from $11 at Citi 06/01/20 Jefferies Jefferies 'underwhelmed' by CytomX presentations at ASCO, downgrades to Hold CTMX CytomX Therapeutics $8.48 / +0.55 (+6.94%) 11/05/20 CytomX Therapeutics reports Q3 EPS (32c), consensus (48c)
Initiation	Philip Morris initiated with a Market Perform at Bernstein » 16:36 01/19/21 01/19 16:36 01/19/21 16:36 PM Philip Morris $81.90 / +0.94 (+1.16%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PM Philip Morris $81.90 / +0.94 (+1.16%) 01/11/21 Philip Morris appoints Jorge Insuasty as chief life sciences officer 12/10/20 Philip Morris chairman Camilleri to retire, Calantzopoulos named exec chairman 12/07/20 Altria confirms FDA authorizes sale of IQOS 3 in U.S. 12/07/20 FDA authorizes Philip Morris IQOS 3 for sale in U.S. PM Philip Morris $81.90 / +0.94 (+1.16%) 01/08/21 Citi Citi 'very bullish' on Philip Morris, ups price target to $105 12/15/20 Edward Jones Philip Morris downgraded to Hold from Buy at Edward Jones 11/23/20 UBS Philip Morris downgraded to Neutral from Buy at UBS 11/18/20 Piper Sandler Philip Morris price target raised to $110 from $98 at Piper Sandler PM Philip Morris $81.90 / +0.94 (+1.16%) 10/20/20 Philip Morris raises FY20 adjusted EPS view to $5.05-$5.10, consensus $5.09 10/20/20 Philip Morris reports Q3 adjusted EPS $1.42, consensus $1.36 09/10/20 Philip Morris sees Q3 reported EPS broadly in line with last year's adj. EPS 09/10/20 Philip Morris sees FY20 adjusted EPS $5.00-$5.07, consensus $5.08 PM Philip Morris $81.90 / +0.94 (+1.16%) 09/09/20 Youth vaping slips significantly in the U.S., WSJ reports 08/28/20 California lawmakers approve menthol cigarette ban, WSJ reports 08/28/20 California lawmakers approve menthol cigarette ban, WSJ reports 07/21/20 Puff Bar e-cigarettes banned by FDA, WSJ reports PM Philip Morris $81.90 / +0.94 (+1.16%) 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 08/28/20 Fly Intel: Wall Street's top stories for Friday 02/04/21 Philip Morris - PM PM Philip Morris $81.90 / +0.94 (+1.16%) 01/04/21 Philip Morris put volume heavy and directionally bearish 10/20/20 Unusually active option classes on open October 20th 10/14/20 $3M call block in Phillip Morris suggests 1.9M share overwrite 10/07/20 Philip Morris call volume above normal and directionally bullish
Initiation	PepsiCo initiated with an Underperform at Bernstein » 16:35 01/19/21 01/19 16:35 01/19/21 16:35 PEP PepsiCo $142.04 / +0.64 (+0.45%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PEP PepsiCo $142.04 / +0.64 (+0.45%) 12/01/20 PepsiCo, UEFA Champions League continue global partnership 11/24/20 Dick's Sporting names Lauren Hobart as CEO, succeeding Edward Stack 11/17/20 Bang Energy terminates distributor partnership with PepsiCo 11/17/20 PepsiCo names Dr. Pietro Antonio Tataranni as Chief Medical Officer PEP PepsiCo $142.04 / +0.64 (+0.45%) 01/06/21 Fly Intel: Top five analyst downgrades 01/06/21 Evercore ISI PepsiCo downgraded to In Line to reflect macro view at Evercore ISI 01/06/21 Evercore ISI PepsiCo downgraded to In Line from Outperform at Evercore ISI 01/04/21 Fly Intel: Top five analyst downgrades PEP PepsiCo $142.04 / +0.64 (+0.45%) 10/01/20 PepsiCo sees FY core EPS about $5.50, consensus $5.36 10/01/20 PepsiCo reports Q3 adjusted EPS $1.66, consensus $1.49 09/30/20 Notable companies reporting before tomorrow's open 09/30/20 Notable companies reporting before tomorrow's open PEP PepsiCo $142.04 / +0.64 (+0.45%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 09/14/20 PepsiCo to launch Driftwell sleep aid beverage, CNBC reports PEP PepsiCo $142.04 / +0.64 (+0.45%) 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 01/04/21 Airbnb, DoorDash coverage initiations among today's top calls on Wall Street 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/12/20 Twitter, Pepsi upgrades among today's top calls on Wall Street 02/11/21 PepsiCo - PEP PEP PepsiCo $142.04 / +0.64 (+0.45%) 15:00 Today $1.2M upside call Seller in PepsiCo 09/30/20 Unusually active option classes on open September 30th 09/29/20 Unusually active option classes on open September 29th 09/28/20 Unusually active option classes on open September 28th
Earnings	Fulton Financial reports Q4 EPS 30c, consensus 31c » 16:34 01/19/21 01/19 16:34 01/19/21 16:34 FULT Fulton Financial $14.79 / +0.28 (+1.93%) "We were pleased… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FULT Fulton Financial $14.79 / +0.28 (+1.93%) 11/25/20 Fulton Financial declares special cash dividend 11/23/20 Fulton Financial acquires all outstanding stock of BenefitWorks 10/21/20 Fulton Financial: Previous 2020 guidance withdrawn due to impact from COVID-19 10/21/20 Fulton Financial sees Q4 net interest income $153M-$158M FULT Fulton Financial $14.79 / +0.28 (+1.93%) 06/17/20 Raymond James Fulton Financial upgraded to Outperform from Market Perform at Raymond James 06/01/20 Stephens Fulton Financial initiated with an Equal Weight at Stephens FULT Fulton Financial $14.79 / +0.28 (+1.93%) 10/20/20 Fulton Financial reports Q3 EPS 38c, consensus 20c 07/21/20 Fulton Financial reports Q2 EPS 24c, consensus 10c 01/20/21 Fulton Financial - FULT
Earnings	Bank First National reports Q4 EPS $1.49 , two estimates $1.32 » 16:34 01/19/21 01/19 16:34 01/19/21 16:34 BFC Bank First National $67.50 / -0.25 (-0.37%) Reports Q4 net interest… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Earnings BFC Bank First National $67.50 / -0.25 (-0.37%) 10/20/20 Bank First National reports Q3 EPS $1.42, consensus $1.03

Initiation	Keurig Dr Pepper initiated with an Outperform at Bernstein » 16:34 01/19/21 01/19 16:34 01/19/21 16:34 KDP Keurig Dr Pepper $31.81 / -0.06 (-0.19%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly KDP Keurig Dr Pepper $31.81 / -0.06 (-0.19%) 11/24/20 Keurig Dr Pepper to acquire certain rights to KDP brands 10/28/20 Keurig Dr Pepper signs distribution pact with The Honickman Companies 10/26/20 Keurig Dr Pepper: Snapple, CORE transition to 100% recycled plastic bottles 09/10/20 Keurig Dr Pepper holder Mondelez reduces stake by $363M KDP Keurig Dr Pepper $31.81 / -0.06 (-0.19%) 01/06/21 Fly Intel: Top five analyst downgrades 01/06/21 Evercore ISI Keurig Dr Pepper downgraded to In Line on macro view at Evercore ISI 01/06/21 Evercore ISI Keurig Dr Pepper downgraded to In Line from Outperform at Evercore ISI 12/07/20 Wells Fargo Keurig Dr Pepper initiated with an Equal Weight at Wells Fargo KDP Keurig Dr Pepper $31.81 / -0.06 (-0.19%) 10/29/20 Keurig Dr Pepper sees FY20 adj. EPS at high end of $1.38-$1.40, consensus $1.40 10/29/20 Keurig Dr Pepper reports Q3 adj. EPS 39c, consensus 37c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 17 Nov 18 Aug 03 Aug 21 May 05 Mar KDP Keurig Dr Pepper $31.81 / -0.06 (-0.19%) 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 09/14/20 Fly Insider: Karuna, DexCom among weeks notable insider trades 08/26/20 Nio's second upgrade this week among today's top calls on Wall Street
Initiation	Monster Beverage initiated with a Market Perform at Bernstein » 16:32 01/19/21 01/19 16:32 01/19/21 16:32 MNST Monster Beverage $90.06 / -1.71 (-1.86%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly MNST Monster Beverage $90.06 / -1.71 (-1.86%) 01/14/21 Monster Beverage announces Hilton Schlosberg as co-CEO, Thomas Kelly as CFO 11/05/20 Monster Beverage not experiencing significant raw material shortages 11/05/20 Monster Beverage doesn't see COVID having material impact on liquidity 10/30/20 Monster Beverage appoints James Dinkins as director of the board MNST Monster Beverage $90.06 / -1.71 (-1.86%) 01/15/21 Truist Monster Beverage price target raised to $105 from $95 at Truist 01/15/21 Deutsche Bank Monster Beverage price target raised to $102 from $99 at Deutsche Bank 01/15/21 Citi Monster Beverage price target raised to $99 from $89 at Citi 01/08/21 Stifel Monster Beverage price target boosted to $105, named a 2021 favorite at Stifel MNST Monster Beverage $90.06 / -1.71 (-1.86%) 11/05/20 Monster Beverage reports Q3 EPS 65c, consensus 63c 11/05/20 Notable companies reporting after market close 08/04/20 Monster Beverage provides update on COVID-19 impact 08/04/20 Monster Beverage reports Q2 EPS 59c, consensus 49c MNST Monster Beverage $90.06 / -1.71 (-1.86%) 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 11/03/20 Pinduoduo, Monster Beverage upgrades among today's top calls on Wall Street 08/04/20 Fly Intel: After-Hours Movers
Syndicate	Chimerix files to sell $75M in common stock » 16:32 01/19/21 01/19 16:32 01/19/21 16:32 CMRX Chimerix $8.08 / +0.15 (+1.89%) Jefferies and Cowen are… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CMRX Chimerix $8.08 / +0.15 (+1.89%) 01/08/21 Chimerix acquires Oncoceutics for $78M 12/07/20 Chimerix announces FDA acceptance of NDA for brincidofovir 11/05/20 Chimerix announces expected upcoming milestones 08/10/20 Chimerix announces expected upcoming milestones CMRX Chimerix $8.08 / +0.15 (+1.89%) 01/11/21 H.C. Wainwright Chimerix price target raised to $16 from $7 at H.C. Wainwright 05/21/20 JonesTrading Chimerix initiated with a Buy at JonesTrading CMRX Chimerix $8.08 / +0.15 (+1.89%) 11/05/20 Chimerix reports Q3 EPS (18c), consensus (17c) 08/10/20 Chimerix reports Q2 EPS (16c), consensus (17c) 21 Jan CMRX Chimerix $8.08 / +0.15 (+1.89%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 12/07/20 Fly Intel: Pre-market Movers 04/07/21 PDUFA Date for Brincidofovir
Initiation	Coca-Cola initiated with an Outperform at Bernstein » 16:31 01/19/21 01/19 16:31 01/19/21 16:31 KO Coca-Cola $48.51 / -0.19 (-0.39%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KO Coca-Cola $48.51 / -0.19 (-0.39%) 01/11/21 Acreage Holdings appoints Katie Bayne as board member 01/03/21 Fly Intel: Top five weekend stock stories 12/20/20 Fly Intel: Top five weekend stock stories 11/16/20 Berkshire Hathaway exits Costco position, reduces stake in Wells Fargo KO Coca-Cola $48.51 / -0.19 (-0.39%) 01/13/21 HSBC Coca-Cola price target lowered to $58 from $61 at HSBC 01/07/21 Fly Intel: Top five analyst downgrades 01/07/21 JPMorgan Coca-Cola downgraded to Neutral on tax risks at JPMorgan 01/07/21 JPMorgan Coca-Cola downgraded to Neutral from Overweight at JPMorgan KO Coca-Cola $48.51 / -0.19 (-0.39%) 10/22/20 Coca-Cola sees 'minimal currency impact' on FY21 net revenue, income 10/22/20 Coca-Cola says Q4 revenues expected to include 3% currency headwind 10/22/20 Coca-Cola says FY20 results 'cannot be reasonably estimated at this time' 10/22/20 Coca-Cola reports Q3 adjusted EPS 55c, consensus 46c KO Coca-Cola $48.51 / -0.19 (-0.39%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 01/02/21 Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 12/17/20 Coca-Cola reducing U.S. staff by 12%, cutting 2,200 jobs globally, WSJ reports KO Coca-Cola $48.51 / -0.19 (-0.39%) 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 01/04/21 Airbnb, DoorDash coverage initiations among today's top calls on Wall Street 12/17/20 Fly Intel: Wall Street's top stories for Thursday 02/10/21 Coca-Cola - KO KO Coca-Cola $48.51 / -0.19 (-0.39%) 11/10/20 Coca Cola call volume above normal and directionally bullish 10/30/20 Coca Cola put volume heavy and directionally bearish 10/22/20 Unusually active option classes on open October 22nd 09/02/20 Coca Cola call volume above normal and directionally bullish
Initiation	Estee Lauder initiated with an Outperform at Bernstein » 16:31 01/19/21 01/19 16:31 01/19/21 16:31 EL Estee Lauder $248.44 / -0.79 (-0.32%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EL Estee Lauder $248.44 / -0.79 (-0.32%) 12/08/20 Pulmonx appoints Georgia Garinois-Melenikiotou, Thomas Burns to board 11/23/20 Estee Lauder chairman sells 8K shares of common stock 11/02/20 Estee Lauder jumps 5% to $231.99 after Q1 earnings beat 11/02/20 Estee Lauder: COVID causing 'significant disruption' in operating environment EL Estee Lauder $248.44 / -0.79 (-0.32%) 01/04/21 Raymond James Estee Lauder downgraded to Market Perform from Outperform at Raymond James 01/04/21 Raymond James Estee Lauder downgraded to Market Perform from Outperform at Raymond James 12/24/20 Citi Estee Lauder price target raised to $258 from $239 at Citi 12/15/20 RBC Capital Estee Lauder price target raised to $271 from $258 at RBC Capital EL Estee Lauder $248.44 / -0.79 (-0.32%) 11/02/20 Estee Lauder not providing guidance for FY21 11/02/20 Estee Lauder sees Q2 adjusted EPS $1.45-$1.60, consensus $1.72 11/02/20 Estee Lauder reports Q1 adjusted EPS $1.44, consensus 90c 08/20/20 Estee Lauder not providing guidance for FY21 EL Estee Lauder $248.44 / -0.79 (-0.32%) 08/08/20 Estee Lauder stock could shine after pandemic, Barron's says EL Estee Lauder $248.44 / -0.79 (-0.32%) 11/23/20 Fly Insider: Organogenesis, Estee Lauder among weeks notable insider trades 11/02/20 Fly Intel: Pre-market Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 09/29/20 Hersey, Best Buy upgrades among today's top calls on Wall Street 02/05/21 Estee Lauder - EL EL Estee Lauder $248.44 / -0.79 (-0.32%) 08/21/20 Early notable gainers among liquid option names on August 21st

Initiation	Clorox initiated with a Market Perform at Bernstein » 16:30 01/19/21 01/19 16:30 01/19/21 16:30 CLX Clorox $196.50 / -0.95 (-0.48%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CLX Clorox $196.50 / -0.95 (-0.48%) 12/10/20 Clorox signs 'America Is All In' statement supporting action on climate change 11/23/20 Visa names Clorox CEO Rendle to board of directors 11/11/20 United Airlines now using Clorox Total 360 System to disinfect terminals 11/02/20 Clorox CEO: Demand has been incredible CLX Clorox $196.50 / -0.95 (-0.48%) 12/14/20 Fly Intel: Top five analyst upgrades NewPage 12/14/20 Citi Clorox upgraded to Buy from Neutral at Citi 12/07/20 Wells Fargo Clorox initiated with an Overweight at Wells Fargo 12/07/20 Wells Fargo Church & Dwight initiated with an Equal Weight at Wells Fargo CLX Clorox $196.50 / -0.95 (-0.48%) 11/02/20 Clorox sees double digit sales growth in Q2, consensus $1.66B 11/02/20 Clorox now sees FY21 EPS $7.70-$7.95, consensus $7.69 11/02/20 Clorox reports Q1 EPS $3.22, consensus $2.32 08/03/20 Clorox sees FY21 EPS down mid-single-digit to up mid-single-digit CLX Clorox $196.50 / -0.95 (-0.48%) 08/04/20 Clorox to be understocked with disinfecting wipes until next year, Reuters says CLX Clorox $196.50 / -0.95 (-0.48%) 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 11/02/20 Fly Intel: Wall Street's top stories for Monday 11/02/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: Pre-market Movers 02/04/21 Clorox - CLX CLX Clorox $196.50 / -0.95 (-0.48%) 01/04/21 Clorox put volume heavy and directionally bearish 11/02/20 Early notable gainers among liquid option names on November 2nd 09/21/20 Early notable gainers among liquid option names on September 21st 08/03/20 Unusually active option classes on open August 3rd
Initiation	Kimberly-Clark initiated with a Market Perform at Bernstein » 16:30 01/19/21 01/19 16:30 01/19/21 16:30 KMB Kimberly-Clark $131.64 / +0.4 (+0.30%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KMB Kimberly-Clark $131.64 / +0.4 (+0.30%) 01/06/21 Columbia Sportswear names Starbucks' John Culver to board of directors 10/22/20 Kimberly-Clark falls -6.8% 10/22/20 Kimberly-Clark falls -6.3% 10/22/20 Kimberly-Clark CEO says 'track to achieve excellent financial results this year' KMB Kimberly-Clark $131.64 / +0.4 (+0.30%) 12/07/20 Wells Fargo Kimberly-Clark initiated with an Underweight at Wells Fargo 10/16/20 Fly Intel: Top five analyst initiations 10/16/20 Fly Intel: Top five analyst downgrades 10/16/20 JPMorgan Kimberly-Clark downgraded to Neutral on valuation at JPMorgan KMB Kimberly-Clark $131.64 / +0.4 (+0.30%) 10/22/20 Kimberly-Clark raises FY20 net sales growth view to 2%-3% from 1%-2% 10/22/20 Kimberly-Clark raises FY20 adj. EPS view to $7.50-$7.65 from $7.40-$7.60 10/22/20 Kimberly-Clark reports Q3 adjusted EPS $1.72, consensus $1.75 10/21/20 Notable companies reporting before tomorrow's open KMB Kimberly-Clark $131.64 / +0.4 (+0.30%) 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/22/20 Fly Intel: Wall Street's top stories for Thursday 10/22/20 Fly Intel: Wall Street's top stories at midday 10/22/20 Fly Intel: Pre-market Movers 01/25/21 Kimberly-Clark - KMB
Options	Preliminary option volume of 37.2M today » 16:30 01/19/21 01/19 16:30 01/19/21 16:30 Preliminary option volume… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Initiation	Procter & Gamble initiated with a Market Perform at Bernstein » 16:29 01/19/21 01/19 16:29 01/19/21 16:29 PG Procter & Gamble $133.56 / -1.275 (-0.95%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PG Procter & Gamble $133.56 / -1.275 (-0.95%) 01/05/21 Procter & Gamble to terminate deal to buy Billie after FTC challenge 12/09/20 Procter & Gamble names Andre Schulten as CFO 12/08/20 FTC sues to block Procter & Gamble's acquisition of Billie, Inc. 12/08/20 FTC sues to block Procter & Gamble's acquisition of Billie, Inc. PG Procter & Gamble $133.56 / -1.275 (-0.95%) 01/13/21 Deutsche Bank Procter & Gamble price target raised to $159 from $156 at Deutsche Bank 01/06/21 Evercore ISI PepsiCo downgraded to In Line to reflect macro view at Evercore ISI 12/07/20 Wells Fargo Colgate-Palmolive initiated with an Underweight at Wells Fargo 12/07/20 Wells Fargo Procter & Gamble initiated with an Overweight at Wells Fargo PG Procter & Gamble $133.56 / -1.275 (-0.95%) 13:41 Today Notable companies reporting before tomorrow's open 10/20/20 Procter & Gamble raises FY21 core EPS view to up 5%-8% from up 3%-7% 10/20/20 Procter & Gamble reports Q1 core EPS $1.63, consensus $1.41 07/30/20 P&G sees FY21 core EPS 3%-7% of FY20 core EPS of $5.12, consensus $5.23 PG Procter & Gamble $133.56 / -1.275 (-0.95%) 11/13/20 Procter & Gamble new disinfectant on pace for $200M in sales, WSJ reports 10/13/20 P&G investors approve proposal for deforestation report, Bloomberg says PG Procter & Gamble $133.56 / -1.275 (-0.95%) 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 01/20/21 Procter & Gamble - PG PG Procter & Gamble $133.56 / -1.275 (-0.95%) 12/09/20 Notable open interest changes for December 9th 10/20/20 Unusually active option classes on open October 20th
Initiation	Colgate-Palmolive initiated with an Underperform at Bernstein » 16:28 01/19/21 01/19 16:28 01/19/21 16:28 CL Colgate-Palmolive $80.84 / -1.05 (-1.28%) Bernstein analyst Callum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CL Colgate-Palmolive $80.84 / -1.05 (-1.28%) 10/30/20 Colgate-Palmolive CFO Henning Jakobsen to retire, Stanley Sutula to succeed 10/30/20 Colgate-Palmolive reports Q3 adjusted gross profit margin 61.2%, up 220 bps 10/30/20 Colgate-Palmolive CEO says 'better visibility for the balance of the year' 07/31/20 Colgate-Palmolive reports Q2 base business gross profit margin 60.8% CL Colgate-Palmolive $80.84 / -1.05 (-1.28%) 01/06/21 Evercore ISI PepsiCo downgraded to In Line to reflect macro view at Evercore ISI 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 RBC Capital Colgate-Palmolive downgraded to Sector Perform from Outperform at RBC Capital 01/04/21 RBC Capital Colgate-Palmolive downgraded to Sector Perform from Outperform at RBC Capital CL Colgate-Palmolive $80.84 / -1.05 (-1.28%) 10/30/20 Colgate-Palmolive sees FY20 revenue 'up mid-single digits,' consensus $16B 10/30/20 Colgate-Palmolive reports Q3 adjusted EPS 79c, consensus 70c 10/29/20 Notable companies reporting before tomorrow's open 10/29/20 Notable companies reporting before tomorrow's open CL Colgate-Palmolive $80.84 / -1.05 (-1.28%) 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/30/20 Fly Intel: Pre-market Movers 01/29/21 Colgate-Palmolive - CL CL Colgate-Palmolive $80.84 / -1.05 (-1.28%) 09/01/20 Colgate Palmolive put volume heavy and directionally bearish

Conference/Events	Moody's to hold a webinar » 16:28 01/19/21 01/19 16:28 01/19/21 16:28 MCO Moody's $269.51 / +2.84 (+1.06%) Europe's Economic… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MCO Moody's $269.51 / +2.84 (+1.06%) 01/04/21 Moody's acquires Catylist, terms undisclosed 11/30/20 FactSet, Moody's higher after IHS Markit gets acquired by S&P Global 10/29/20 Moody's reports Q3 MIS revenue $825M, up 11% y/y 10/22/20 Moody's names Robert Fauber CEO MCO Moody's $269.51 / +2.84 (+1.06%) 12/31/20 Raymond James CCXI news could be catalyst for Moody's to pivot China plans, says Raymond James 12/17/20 Barclays Moody's price target raised to $320 from $305 at Barclays 11/30/20 Deutsche Bank Moody's initiated with a Hold at Deutsche Bank 11/26/20 Atlantic Equities Moody's upgraded to Overweight from Neutral at Atlantic Equities MCO Moody's $269.51 / +2.84 (+1.06%) 10/29/20 Moody's raises FY20 adjusted EPS view to $9.95-$10.15 from $8.80-$9.20 10/29/20 Moody's reports Q3 adjusted EPS $2.69, consensus $2.10 07/30/20 Moody's raises, narrows FY20 adj. EPS view to $8.80-$9.20, consensus $8.66 07/30/20 Moody's reports Q2 adj. EPS $2.81, consensus $2.21 02/12/21 Moody's - MCO
Downgrade	Intercorp downgraded to Sector Perform from Outperform at Scotiabank » 16:27 01/19/21 01/19 16:27 01/19/21 16:27 IFS Intercorp Financial Services $33.68 / -1.28 (-3.66%) Scotiabank analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research IFS Intercorp Financial Services $33.68 / -1.28 (-3.66%) 11/12/20 JPMorgan Intercorp Financial downgraded to Neutral from Overweight at JPMorgan 10/28/20 Scotiabank Credicorp, Intercorp upgraded to Outperform after underperformance at Scotiabank 10/27/20 Scotiabank Intercorp Financial Services upgraded to Outperform from Sector Perform at Scotiabank 06/24/20 Scotiabank Intercorp Financial Services downgraded to Sector Perform from Outperform at Scotiabank
Syndicate	Bionano Genomics announces common stock offering, no amount given » 16:26 01/19/21 01/19 16:26 01/19/21 16:26 BNGO Bionano Genomics $9.12 / +0.705 (+8.38%) Oppenheimer & Co. is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BNGO Bionano Genomics $9.12 / +0.705 (+8.38%) 08:38 Today Bionano Genomics' Saphyr System shows improved MDS detection in publication 01/15/21 Bionano Genomics announces presentations from Cytogenomics Symposium 01/14/21 Bionano Genomics announces presentations from Cytogenomics Symposium 01/13/21 Bionano Genomics announces presentations from Cytogenomics Symposium BNGO Bionano Genomics $9.12 / +0.705 (+8.38%) 12/04/20 Roth Capital Bionano Genomics downgraded to Neutral from Buy at Roth Capital 12/04/20 Roth Capital Bionano Genomics downgraded to Neutral from Buy at Roth Capital 09/24/20 Ladenburg Bionano Genomics initiated with a Buy at Ladenburg 04/08/20 Oppenheimer Oppenheimer bullish on Bionano Genomics, initiates with an Outperform BNGO Bionano Genomics $9.12 / +0.705 (+8.38%) 11/12/20 Bionano Genomics reports Q3 revenue $2.2M, consensus $2.07M. 10/15/20 Bionano Genomics sees Q3 revenue $1.9M-$2.3M, consensus $2.07M 08/13/20 Bionano Genomics reports Q2 net loss ($8.0M) vs. ($7.67M) a year ago 08 Jan BNGO Bionano Genomics $9.12 / +0.705 (+8.38%) 01/15/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Pre-market Movers BNGO Bionano Genomics $9.12 / +0.705 (+8.38%) 01/13/21 Thirteen new option listings and two option delistings on January 13th
Upgrade	UniCredit upgraded to Hold from Sell at Societe Generale » 16:25 01/19/21 01/19 16:25 01/19/21 16:25 UNCFF UniCredit $0.00 / + (+0.00%) , BMDPF Banca Monte dei Paschi di Siena $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals UNCFF UNCFF UniCredit $0.00 / + (+0.00%) 12/01/20 UniCredit CEO Jean Pierre Mustier to retire at end of current mandate UNCFF BMDPF UNCFF UniCredit $0.00 / + (+0.00%) 12/14/20 Goldman Sachs UniCredit downgraded to Buy from Conviction Buy at Goldman Sachs 12/02/20 Berenberg UniCredit downgraded to Hold from Buy at Berenberg 12/01/20 Societe Generale UniCredit downgraded to Sell from Hold at Societe Generale 12/01/20 Societe Generale UniCredit downgraded to Sell from Hold at Societe Generale BMDPF Banca Monte dei Paschi di Siena $0.00 / + (+0.00%) 09/28/20 Morgan Stanley Banca Monte dei Paschi di Siena target lowered to EUR 1.30 at Morgan Stanley UNCFF BMDPF UNCFF UniCredit $0.00 / + (+0.00%) 01/13/21 UniCredit considers Orcel, Thiam for CEO role, FT reports 01/06/21 Italy mulls taking on UniCredit impaired loans to ease MPS sale, Reuters says 09/21/20 Italy discusses possible Monte Paschi stake sale with UniCredit, Bloomberg says BMDPF Banca Monte dei Paschi di Siena $0.00 / + (+0.00%) 11/02/20 Monte dei Paschi CEO says bank needs EUR1.5B-EUR2B in cash, Reuters says
Conference/Events	United Therapeutics to host conference call » 16:25 01/19/21 01/19 16:25 01/19/21 16:25 UTHR United Therapeutics $171.57 / -1.26 (-0.73%) Conference call to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events UTHR United Therapeutics $171.57 / -1.26 (-0.73%) 01/13/21 United Therapeutics: Results from INCREASE study of Tyvaso published in NEJM 12/28/20 Y-mAbs Therapeutics announces sale of priority review voucher 12/28/20 United Therapeutics to acquire PRV for Tyvaso DPI NDA 12/09/20 United Therapeutics receives orphan drug designation for treprostinil from FDA UTHR United Therapeutics $171.57 / -1.26 (-0.73%) 07:53 Today Credit Suisse Insmed price target raised to $60 from $50 at Credit Suisse 12/29/20 BTIG United Therapeutics' treprostinil development uses MannKind technology, say BTIG 10/29/20 Wedbush United Therapeutics price target raised to $255 from $247 at Wedbush 10/29/20 Oppenheimer United Therapeutics price target raised to $175 from $165 at Oppenheimer UTHR United Therapeutics $171.57 / -1.26 (-0.73%) 10/28/20 United Therapeutics reports Q3 EPS $3.84, consensus $2.78 07/29/20 United Therapeutics reports Q2 EPS $3.68, consensus $2.86 16:30 Today United Therapeutics - UTHR

Initiation	Zentalis initiated with an Outperform at Wedbush » 16:24 01/19/21 01/19 16:24 01/19/21 16:24 ZNTL Zentalis $49.35 / +0.28 (+0.57%) Wedbush analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate ZNTL Zentalis $49.35 / +0.28 (+0.57%) 01/06/21 Zentalis initiates patient dosing in three clinical trials 11/09/20 Zentalis expects cash to fund operations into 2023 09/11/20 Zentalis to host KOL meeting on ZN-c3 for treatment of advanced solid tumors 09/01/20 Zentalis appoints Alex Pinto as CLO ZNTL Zentalis $49.35 / +0.28 (+0.57%) 09/28/20 Cantor Fitzgerald Cantor starts 'underappreciated' Zentalis with Overweight, $44 target 09/28/20 Cantor Fitzgerald Zentalis initiated with an Overweight at Cantor Fitzgerald 08/27/20 H.C. Wainwright Zentalis initiated with a Buy at H.C. Wainwright 04/28/20 Fly Intel: Top five analyst initiations ZNTL Zentalis $49.35 / +0.28 (+0.57%) 11/09/20 Zentalis reports Q3 EPS (91c), consensus (81c) 08/13/20 Zentalis reports Q2 EPS (78c), consensus (50c) 30 Jul 03 Apr
Earnings	One Gas expects net income to increase 6%-8% annually from 2020-2025 » 16:24 01/19/21 01/19 16:24 01/19/21 16:24 OGS One Gas $71.35 / -0.585 (-0.81%) Net income is expected to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OGS One Gas $71.35 / -0.585 (-0.81%) 16:16 Today One Gas raises quarterly dividend to 58c from 54c per share OGS One Gas $71.35 / -0.585 (-0.81%) 12/17/20 Stifel One Gas initiated with a Buy at Stifel 11/04/20 Mizuho One Gas price target raised to $81 from $80 at Mizuho 09/25/20 Mizuho Mizuho upgrades One Gas to Buy, says 26% pullback overdone 09/25/20 Mizuho One Gas upgraded to Buy from Neutral at Mizuho OGS One Gas $71.35 / -0.585 (-0.81%) 16:22 Today One Gas sees FY21 EPS $3.68-$3.92, consensus $3.85 16:21 Today One Gas raises FY20 EPS view to $3.66-$3.70 from $3.44-$3.68, consensus $3.61 11/02/20 One Gas reaffirms FY20 EPS view $3.44-$3.68, consensus $3.56 11/02/20 One Gas reports Q3 EPS 39c, consensus 35c
Initiation	Utz Brands initiated with an Overweight at Stephens » 16:23 01/19/21 01/19 16:23 01/19/21 16:23 UTZ Utz Brands $21.75 / -0.8 (-3.55%) Stephens analyst Tim Perz… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly UTZ Utz Brands $21.75 / -0.8 (-3.55%) 01/11/21 Utz Brands to acquire Vitner's brand assets for $25M, sees accretion 12/14/20 Utz Brands completes acquisition of On The Border 11/23/20 Utz Brands CEO: We're really excited about the Truco acquisition 11/12/20 Utz Brands expects Truco to generate about $195M in net sales in FY20 UTZ Utz Brands $21.75 / -0.8 (-3.55%) 12/22/20 Piper Sandler Utz Brands price target raised to $25 from $22 at Piper Sandler 12/21/20 Goldman Sachs Utz Brands reinstated with a Neutral at Goldman Sachs 12/16/20 Barclays Utz Brands price target raised to $23 from $21 at Barclays 11/13/20 Fly Intel: Top five analyst upgrades UTZ Utz Brands $21.75 / -0.8 (-3.55%) 11/05/20 Utz Brands sees FY20 revenue growth 10%-11%, consensus $949.32M 11/05/20 Utz Brands reports Q3 revenue $248.0M, consensus $246.11M UTZ Utz Brands $21.75 / -0.8 (-3.55%) 11/13/20 Disney upgrade among today's top calls on Wall Street 09/21/20 Fly Intel: After-Hours Movers
Initiation	BellRing Brands initiated with an Overweight at Stephens » 16:22 01/19/21 01/19 16:22 01/19/21 16:22 BRBR BellRing Brands $23.58 / -0.61 (-2.52%) Stephens analyst Tim Perz… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BRBR BellRing Brands $23.58 / -0.61 (-2.52%) 11/12/20 BellRing Brands announces $60M share repurchase program 08/07/20 BellRing Brands falls -12.4% BRBR BellRing Brands $23.58 / -0.61 (-2.52%) 01/12/21 Jefferies BellRing Brands price target raised to $30 from $26 at Jefferies 01/06/21 BofA BellRing Brands upgraded to Buy as consumers focus on weight loss at BofA 01/06/21 BofA BellRing Brands upgraded to Buy from Neutral at BofA 12/24/20 Goldman Sachs BellRing Brands price target raised to $31 from $28 at Goldman Sachs BRBR BellRing Brands $23.58 / -0.61 (-2.52%) 11/19/20 BellRing Brands sees FY21 revenue $1.07B-$1.12B, consensus $1.06B 11/19/20 BellRing Brands reports Q4 adj. EPS 25c, consensus 19c 08/06/20 BellRing Brands sees FY20 revenue $960M-$980M, consensus $1.01B 08/06/20 BellRing Brands reports Q3 adjusted EPS 8c, consensus 16c 02/05/21 BellRing Brands - BRBR
Earnings	One Gas sees FY21 EPS $3.68-$3.92, consensus $3.85 » 16:22 01/19/21 01/19 16:22 01/19/21 16:22 OGS One Gas $71.35 / -0.585 (-0.81%) The company's 2021… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OGS One Gas $71.35 / -0.585 (-0.81%) 16:16 Today One Gas raises quarterly dividend to 58c from 54c per share OGS One Gas $71.35 / -0.585 (-0.81%) 12/17/20 Stifel One Gas initiated with a Buy at Stifel 11/04/20 Mizuho One Gas price target raised to $81 from $80 at Mizuho 09/25/20 Mizuho Mizuho upgrades One Gas to Buy, says 26% pullback overdone 09/25/20 Mizuho One Gas upgraded to Buy from Neutral at Mizuho OGS One Gas $71.35 / -0.585 (-0.81%) 16:21 Today One Gas raises FY20 EPS view to $3.66-$3.70 from $3.44-$3.68, consensus $3.61 11/02/20 One Gas reaffirms FY20 EPS view $3.44-$3.68, consensus $3.56 11/02/20 One Gas reports Q3 EPS 39c, consensus 35c 07/27/20 One Gas reaffirms FY20 EPS view $3.44-$3.68, consensus $3.55

Events

Earnings calls, analyst events, roadshows and more

AVO
Today at 17:00

Mission Produce - AVO Conference Calls
JBHT
Today at 17:00

J.B. Hunt - JBHT Conference Calls
ZION
Today at 17:30

Zions Bancorp - ZION Conference Calls
NFLX
Today at 18:00

Netflix - NFLX Conference Calls
MRK ...
Tomorrow at 00:00

PDUFA Date for Vericiguat Government Event
MIND ...
Tomorrow at 00:00

17th Annual Small & Microcap Virtual Investor Conference Conferences

Virtual Conference
Tomorrow at 00:00

Battery & EV Metals Virtual Investor Conference Conferences

Virtual Conference
MCO
Tomorrow at 00:00

Europe's Economic Outlook Conferences

Webinar
Tomorrow at 00:00

Western Institutional Investor Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Asia ESG /Solar & Wind Virtual Seminar Conferences

Virtual Seminar

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital $32.80 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright $17.00-18.00 ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald $1.90-2.00
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

Comtech awarded $2.4M contract from City of Edmonton

TODAY'S FREE FLY STORIES

Get Full Fly Access